SPRYARS Pharmaceuticals, Inc.
$4.57-56% 1Y
$4.57
$4.0752 weeks$13.06
What is the market doing?
Watch
1 to watch, 2 without dataIn a downtrend (−43% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendDowntrendderived · Oct 8, 2026
In a downtrend, below its 50- and 200-day averages. Price is −43% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SPRY is trading
ARS Pharmaceuticals, Inc. is −56% over the past year while the S&P 500 is +18%: 74 points behind the market.
−56%
1-year return · S&P 500 +18%
- vs 200-day average
- −43%
vs 200-day average · a clear downtrend
- RSI (14)
- 62
RSI (14) · neutral
- Below its 52-week high
- 65%
Below its 52-week high
Details›
- Last close2026-10-08
- $4.57
- 1 monthS&P 500 +1.6%
- −12%
- 1 yearS&P 500 +18%
- −56%
- 5 yearsS&P 500 +86%
- −54%
- vs 50-day average$5.15
- −11%
- 52-week high
- $13.06
- 52-week low
- $4.07
- Annualised volatility
- 69%
| Year | Return |
|---|---|
| 2026 (year to date) | −61% |
| 2025 | +10% |
| 2024 | +93% |
| 2023 | −36% |
| 2022 | +28% |
| 2021 | −86% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 2 of 6 | −4.9% |
| Feb | 6 | 3 of 6 | +6.0% |
| Mar | 6 | 2 of 6 | −4.3% |
| Apr | 6 | 2 of 6 | −6.5% |
| May | 6 | 5 of 6 | +3.4% |
| Jun | 6 | 3 of 6 | +5.9% |
| Jul | 6 | 4 of 6 | +3.7% |
| Aug | 6 | 3 of 6 | −3.8% |
| Sep | 6 | 1 of 6 | −22% |
| Oct | 6 | 3 of 6 | −0.78% |
| Nov | 5 | 2 of 5 | +4.4% |
| Dec | 5 | 3 of 5 | +8.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.